Secondary Logo

Institutional members access full text with Ovid®

Current Update on Desmoid Fibromatosis

Ganeshan, Dhakshinamoorthy, MD*; Amini, Behrang, MD, PhD; Nikolaidis, Paul, MD; Assing, Matthew, MD§; Vikram, Raghunandan, MD

Journal of Computer Assisted Tomography: January/February 2019 - Volume 43 - Issue 1 - p 29–38
doi: 10.1097/RCT.0000000000000790
Musculoskeletal Imaging
Buy
SDC

Objective The purpose of this article is to review the etiopathogenesis, molecular cytogenetics, histopathology, clinical features, and multimodality imaging features of desmoid fibromatosis. Recent advances in the management of desmoid fibromatosis will also be discussed.

Conclusions Desmoid fibromatosis is a rare soft tissue neoplasm with a high incidence of local recurrence. Imaging plays an important role in the diagnosis and management of this disease.

From the *Division of Diagnostic Imaging, Body Imaging Section,

Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX;

Northwestern University, Feinberg School of Medicine, Chicago, IL;

§Department of Radiology, Stanford University School of Medicine, Stanford, CA; and

Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

Received for publication June 7, 2018; accepted July 23, 2018.

Correspondence to: Dhakshinamoorthy Ganeshan, MD, Division of Diagnostic Imaging, Body Imaging Section, Unit 1473, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009 (e-mail: dganeshan@mdanderson.org).

The authors declare no conflict of interest.

This study was supported by the NIH/NCI under award number P30 CA016672.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.